Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling. Novo Nordisk's Ozempic will become the first and only GLP-1 drug to be shown to reduce progression of kidney ...
ANZ is facing growing pressure and criticism over allegations it wrongly pillaged the bank accounts of dead customers, and an architect of the nation’s regulatory reforms says the banking major has ...
The Trump transition team is considering ways to shrink, consolidate or eliminate bank regulators in Washington, D.C., a move that would have a massive impact on agencies in charge of protecting ...
From hefty fines imposed on Big Tech players to sector-specific guidelines across industries, governments and regulators worldwide sent a clear message: consumer interest, transparency ...
President-elect Donald Trump has a long list of policy objectives that he wants to implement on “day one.” WSJ explains which of these plans he can carry out on his own, which he’ll need ...